Elvis Cuevas
Overview
Explore the profile of Elvis Cuevas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
692
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cuevas E, Lantz S, Newport G, Divine B, Wu Q, Paule M, et al.
Neurosci Lett
. 2024 Sep;
843:138001.
PMID: 39343694
No abstract available.
2.
Kolahchi Z, Henkel N, Eladawi M, Villarreal E, Kandimalla P, Lundh A, et al.
Int J Mol Sci
. 2024 Aug;
25(15).
PMID: 39126053
Two-thirds of Americans with Alzheimer's disease are women, indicating a profound variance between the sexes. Variances exist between the sexes in the age and intensity of the presentation, cognitive deficits,...
3.
Cuevas E, Guzman A, Burks S, Ramirez-Lee A, Ali S, Imam S
Toxicol Rep
. 2022 Dec;
9:806-813.
PMID: 36518412
The pathophysiology underlying the loss of dopaminergic neurons in Parkinson's disease (PD) is unclear. A gap of knowledge in the molecular and cellular events leading to degeneration of the nigrostriatal...
4.
Apatiga-Perez R, Soto-Rojas L, Campa-Cordoba B, Luna-Viramontes N, Cuevas E, Villanueva-Fierro I, et al.
Metab Brain Dis
. 2021 Aug;
37(1):39-50.
PMID: 34406560
Alzheimer's disease (AD) is clinically characterized by a progressive loss of cognitive functions and short-term memory. AD patients present two distinctive neuropathological lesions: neuritic plaques and neurofibrillary tangles (NFTs), constituted...
5.
Burks S, Rosas-Hernandez H, Alejandro Ramirez-Lee M, Cuevas E, Talpos J
Brain Behav Immun
. 2021 Jan;
95:7-14.
PMID: 33412255
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China in December 2019. On February 11, the World Health Organization (WHO) announced the name for the new illness caused...
6.
Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson's disease
Cuevas E, Burks S, Raymick J, Robinson B, Gomez-Crisostomo N, Escudero-Lourdes C, et al.
Nutr Neurosci
. 2020 Dec;
25(7):1374-1391.
PMID: 33345721
Parkinson's disease (PD) is a progressive motor disease of unknown etiology. Although neuroprotective ability of endogenous bile acid, tauroursodeoxycholic acid (TUDCA), shown in various diseases, including an acute model of...
7.
Sarkar S, Raymick J, Cuevas E, Rosas-Hernandez H, Hanig J
Metab Brain Dis
. 2020 Aug;
35(8):1371-1383.
PMID: 32852699
Although there are multiple histochemical tracers available to label plaques and tangles in the brain to evaluate neuropathology in Alzheimer disease (AD), few of them are versatile in nature and...
8.
Rosas-Hernandez H, Cuevas E, Raymick J, Robinson B, Sarkar S
Neuroscience
. 2020 May;
440:48-55.
PMID: 32450297
Alzheimer's disease (AD) pathology is characterized by amyloid plaques containing amyloid beta (Aβ) peptides, neurofibrillary tangles containing hyperphosphorylated tau protein, and neuronal loss. In addition, Aβ deposition in brain microvessels,...
9.
Inselman A, Liu F, Wang C, Shi Q, Pang L, Mattes W, et al.
Toxicol In Vitro
. 2019 Oct;
64:104471.
PMID: 31628011
For the past five years, Dr. Daniel Acosta has served as the Deputy Director of Research at the National Center for Toxicological Research (NCTR), a principle research laboratory of the...
10.
Rosas-Hernandez H, Burks S, Cuevas E, Ali S
Neurochem Res
. 2019 Sep;
44(11):2546-2555.
PMID: 31529335
Traumatic brain injury (TBI) is defined as damage to the brain that consequently disrupts normal function. Neuronal death, a hallmark of TBI, has been related to the development of neurodegenerative...